3048310 MPDA mesoporous polydopamine 123 3048314 m-PDA m-phenylenediamine 24 3048322 MPDA mesoporous polydopamine nanoparticles 20 3048316 MPDA microphotodiode array 9 3048321 MPDA metal polydopamine frameworks 3 3048311 MPDA metal-containing polydopamine 2 3048315 MPDA mixotrophic partial denitrification/anammox 2 3048350 MPDA ((3-(N,N-dimethylamino)propyl)amido)alkane-di-N-oxides 1 3048346 MPDA alpha-D-mannopyranoside 1 3048347 MPDA loaded-mesoporous polydopamine 1 3048343 MPDA macular perfusion density asymmetry 1 3048344 MPDA magnetic polydopamine 1 3048341 MPDA magnetic polydopamine nanoparticles 1 3048342 MPDA main pancreatic duct abnormalities 1 3048339 MPDA manifold partition discriminant analysis 1 3048340 MPDA material N,N'-diphenyl-N,N'-di-p-tolylbenzene-1,4-diamine 1 3048327 MPDA mean provocative dose of oral aspirin 1 3048328 MPDA medial plateau depression angle 1 3048326 MPDA membership-degree preserving discriminant analysis 1 3048324 MPDA membrane protein drift and assembly 1 3048325 MPDA mesoporous PDA 1 3048323 MPDA mesoporous PDA particles 1 3048320 MPDA mesoporous polydopamine-based 1 3048319 MPDA metal-polydopamine 1 3048318 MPDA methyl phenyldiazoacetate 1 3048348 MPDA Microarray Pooled DNA Analyzer 1 3048317 MPDA minimal pigementation dose for UVA 1 3048338 MPDA moderately/poorly differentiated adenocarcinoma 1 3048329 MPDA modified photon diffusion analysis 1 3048330 MPDA modified with 0.005% tetracycline, 0.01% streptomycin, and 0.1% Igepal CO-630 1 3048336 MPDA modifying polydopamine 1 3048337 MPDA monoperoxydecanoic 1 3048345 MPDA mPEG-modified polydopamine 1 3048335 MPDA multi-scene prioris data augmentation 1 3048349 MPDA Multigrid Position-and-Direction-to-Action 1 3048333 MPDA multipoint dynamic aggregation 1 3048351 MPDA MXene-based platform 1 3048334 MPDA nanomaterial-mesoporous polydopamine 1 3048331 MPDA p-10,12-pentacosadiyne-1-N-(3,6,9-trioxaundecylamide)-alpha-D-mannopyranoside 1 3048332 MPDA p-methoxyphenyl dichloroacetate 1